103 related articles for article (PubMed ID: 9688372)
1. Octreotide, a somatostatin analogue, alters ovarian sensitivity to gonadotrophin stimulation as measured by the follicle stimulating hormone threshold in polycystic ovary syndrome.
van der Meer M; de Boer JA; Hompes PG; Schoemaker J
Hum Reprod; 1998 Jun; 13(6):1465-9. PubMed ID: 9688372
[TBL] [Abstract][Full Text] [Related]
2. The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries.
Prelevic GM; Ginsburg J; Maletic D; Hardiman P; Okolo S; Balint-Peric L; Thomas M; Orskov H
Hum Reprod; 1995 Jan; 10(1):28-32. PubMed ID: 7745065
[TBL] [Abstract][Full Text] [Related]
3. The effect of sequential administration of octreotide alone and octreotide/growth hormone simultaneously on buserelin stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
Piaditis GP; Hatziioanidis AH; Trovas GP; Misichronis GS; Kounadi TG; Devetzaki OA; Andronis CK; Rangou DB; Chlouverakis CS
Clin Endocrinol (Oxf); 1996 Nov; 45(5):595-604. PubMed ID: 8977757
[TBL] [Abstract][Full Text] [Related]
4. Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome.
Hugues JN; Cédrin-Durnerin I; Avril C; Bulwa S; Hervé F; Uzan M
Hum Reprod; 1996 Dec; 11(12):2581-4. PubMed ID: 9021354
[TBL] [Abstract][Full Text] [Related]
5. Effects of the somatostatin analogue, octreotide, in polycystic ovary syndrome.
Prelević GM; Wurzburger MI; Balint-Perić L; Hardiman P; Okolo S; Maletić D; Ginsburg J
Metabolism; 1992 Sep; 41(9 Suppl 2):76-9. PubMed ID: 1518438
[TBL] [Abstract][Full Text] [Related]
6. Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome.
Van Der Meer M; Hompes PG; De Boer JA; Schats R; Schoemaker J
J Clin Endocrinol Metab; 1998 Feb; 83(2):423-6. PubMed ID: 9467551
[TBL] [Abstract][Full Text] [Related]
7. Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndrome.
van der Meer M; Hompes PG; Scheele F; Schoute E; Veersema S; Schoemaker J
Hum Reprod; 1994 Sep; 9(9):1612-7. PubMed ID: 7836509
[TBL] [Abstract][Full Text] [Related]
8. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?
La Marca A; Pati M; Giulini S; Levratti P; Caretto S; Volpe A
Gynecol Endocrinol; 2005 Nov; 21(5):292-4. PubMed ID: 16373249
[TBL] [Abstract][Full Text] [Related]
9. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M
Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
[TBL] [Abstract][Full Text] [Related]
10. The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome.
Scheele F; Hompes PG; van der Meer M; Schoute E; Schoemaker J
Hum Reprod; 1993 May; 8(5):699-704. PubMed ID: 8314962
[TBL] [Abstract][Full Text] [Related]
11. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.
Dale PO; Tanbo T; Haug E; Abyholm T
Hum Reprod; 1998 Mar; 13(3):567-70. PubMed ID: 9572412
[TBL] [Abstract][Full Text] [Related]
12. Lack of insulin-like growth factor binding protein-3 variation after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization.
Amato G; Izzo A; Tucker AT; Bellastella A
Fertil Steril; 1999 Sep; 72(3):454-7. PubMed ID: 10519616
[TBL] [Abstract][Full Text] [Related]
13. Combined somatostatin analog and follicle-stimulating hormone for women with polycystic ovary syndrome resistant to conventional treatment.
Lidor A; Soriano D; Seidman DS; Dor J; Mashiach S; Rabinovici J
Gynecol Endocrinol; 1998 Apr; 12(2):97-101. PubMed ID: 9610422
[TBL] [Abstract][Full Text] [Related]
14. Growth of the dominant follicle is similar to normal in patients with gonadotrophin-stimulated polycystic ovary syndrome exhibiting monofollicular development during a decremental dose regimen.
Schoot DC; Hop WC; Pache TD; de Jong FH; Fauser BC
Acta Endocrinol (Copenh); 1993 Aug; 129(2):126-9. PubMed ID: 8372596
[TBL] [Abstract][Full Text] [Related]
15. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
[TBL] [Abstract][Full Text] [Related]
16. The role of endogenous gonadotropin release in the etiology of ovarian enlargement during purified urinary follicle-stimulating hormone therapy.
Mizunuma H; Takagi T; Yamada K; Andoh K; Ibuki Y; Igarashi M
Fertil Steril; 1991 Jan; 55(1):66-72. PubMed ID: 1898893
[TBL] [Abstract][Full Text] [Related]
17. Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome.
Strowitzki T; Seehaus D; Korell M; Hepp H
J Reprod Med; 1994 Jul; 39(7):499-503. PubMed ID: 7966037
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
Dale PO; Tanbo T; Haug E; Abyholm T
Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome.
Homburg R; Orvieto R; Bar-Hava I; Ben-Rafael Z
Hum Reprod; 1996 Apr; 11(4):716-9. PubMed ID: 8671313
[TBL] [Abstract][Full Text] [Related]
20. Utero-ovarian arterial blood flow and hormonal profile in patients with polycystic ovary syndrome.
Vrtacnik-Bokal E; Meden-Vrtovec H
Hum Reprod; 1998 Apr; 13(4):815-21. PubMed ID: 9619530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
